Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited

Bone Marrow Transplantation

Volumn 26, Issue 6, 2000, Pages 591-597

  Barry, S M ^a   Johnson, M A ^a   Janossy, G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bone marrow transplantation; Bronchoalveolar lavage; Cytomegalovirus pneumonitis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; IMMUNOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIROGENESIS; VIRUS LOAD; VIRUS PNEUMONIA;

EID: 0033799616     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702562     Document Type: Review

References (59)

1. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
2. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs
3. Cytotoxic T. cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients
4. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
5. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis
6. Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction. Characterization of bronchoalveolar lavage cells
7. Activity of 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia
8. Open-lung biopsy in patients with acute respiratory distress syndrome
9. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: Relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
10. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence
11. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
12. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation
13. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
14. Resolution of early cytome-galovirus (CMV) infection after leukocyte transfusion therapy from a CMV seropositive donor
15. Adoptive immunotherapy for interstitial pneumonia associated with cytomegalovirus infection
16. Clinical significance of CMV-specific T helper responses in lung transplant recipients
17. Cytomegalovirus infection following haematopoietic stem cell transplantation
18. Risk factors for cytomegalovirus infection after human marrow transplantation
19. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies
20. Thymic aging and T-cell regeneration
21. Reconstruction of the haemopoietic and immune systems after marrow transplantation
22. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies
23. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia
24. Restoration of T-cell homeostasis after T-cell depletion
25. T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow
26. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors
27. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions
28. Lymphokine production by T-cell clones after human bone marrow transplantation
29. Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
30. In vivolex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT
31. Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins
32. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors
33. Life-threatening infections occurring more than 3 months after BMT. 18 UK bone marrow transplant teams
34. Late infections after allogeneic bone marrow transplantations: Comparison of incidence in related and unrelated donor transplant recipients
35. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants
36. Pulmonary cell populations in recipients of bone marrow transplants with interstitial pneumonitis
37. Distinctive functional characteristics of human T lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody
38. Large granular lymphocytes in bronchoalveolar lavage fluids from immuno-compromised patients with cytomegalovirus pneumonitis
39. Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia
40. Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity
41. Monoclonal anti-T-cell antibodies react with circulating myeloid leukemia cells and normal tissue macrophages
42. Cytomegalovirus pneumonitis in patients with AIDS. Findings in an autopsy series
43. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS
44. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?
45. Severe cytomegalovirus pneumonitis in HIV infected patients with higher than average CD4 counts
46. Cytomegalovirus (CMV) pneumonitis in AIDS patients: The result of intensive CMV replication?
47. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
48. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
49. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
50. Paradoxical reactions in HIV and pulmonary TB
51. Pulmonary tuberculosis in AIDS patients: Transient chest radiographic worsening after initiation of antiretroviral therapy
52. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
53. Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy
54. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis
55. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
56. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
57. Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression
58. Human cytomegalo-virus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes
59. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression